Sep 10,2020

Belgian Scale-up Oncomfort Raises €10 Million in Series A Funding

Oncomfort, the Belgian inventor of and leader in Digital Sedation – a method for relieving patients’ pain and anxiety without medication – announces the completion of a €10 million Series A funding round co-led by two prominent institutional investors: Debiopharm and Crédit Mutuel Innovation. Founded in 2017, Oncomfort is a Belgian scale-up specialized in Digital Sedation, a completely new method for relieving patients’ pain and anxiety through treatment with clinically proven sessions of therapeutic Virtual Reality. Oncomfort plans to use this investment to develop its innovative digital therapy solutions and accelerate its international expansion.

FUNDING SERIES A
View Analyst & Ambassador Comments
Go to original news
Oct 28,2020

Sidekick Health Raises $20 million Series A Funding

Nordic digital therapeutics company, Sidekick Health, has closed a $20 million Series A led by pan-European VC Wellington Partners and healthcare focused VC Asabys Partners. Existing investors, Novator and Frumtak Ventures, also participated in the oversubscribed round. Sidekick Health’s platform addresses multiple therapeutic areas — offering what’s described as ‘evidence-based’, custom gamified digital therapeutics packages for conditions including diabetes, ulcerative colitis and smoking cessation. The new funding is going towards “further growth”, per Thorgeirsson — “both in terms of expanding the product but also accelerating our growth in both Europe and into the US market”. “We’re investing funds into the growth instead of aiming for profitability at this point,” he adds.

FUNDING SERIES A
View Analyst & Ambassador Comments
Go to original news
Dec 03,2020

German startup Perfood closes €5M Series A for migraine therapy

German digital therapeutic startup, Perfood, has received €5 million in a Series A funding round to launch its first prescription therapeutic sinCephalea for the treatment of migraines and to prepare for the expansion of the technology into other countries. This includes the conduction of clinical studies to advance its digital therapeutics products. Boehringer Ingelheim Venture Fund led the round and is joined by German family office UV-Cap and Swiss investment platform investiere.

FUNDING SERIES A
View Analyst & Ambassador Comments
Go to original news
Jan 08,2019

Digital therapeutics company HealthBeacon closes $12m Series A investment round

Dublin-headquartered digital therapeutics company HealthBeacon has closed a $12m Series A investment round to fuel its push into the US, Canada and UK markets. The company, which develops smart tools to manage medication, made the announcement at the JP Morgan Digital Medicine and Medtech Showcase in San Francisco this week. Its smart sharps bin solution aims to help patients who self-inject medications at home improve adherence to prescription schedules.

FUNDING SERIES A
View Analyst & Ambassador Comments
Go to original news
Apr 09,2018

Finnish patient monitoring platform closes $5.4M funding round

Helsinki, Finland-based Kaiku Health, which offers digital patient monitoring and patient-reported outcome services designed for several medical specialties, has announced $5.4 million (4.4 million euros) in Series A financing. The round was led by Debiopharm Innovation Fund SA and Tesi, with additional participation from new investor Prodeko Ventures and returning supporters Reaktor Ventures, Metsola Ventures, and Athensmed.

FUNDING SERIES A
View Analyst & Ambassador Comments
Go to original news
Jun 29,2018

Neurologic-focused digital therapeutics group MedRhythms raises $5m

Early stage medtech company MedRhythms said today it raised $5.3 million in a Series A round of financing to help support its platform intended to use neurologic interventions to measure and improve walking. The Portland, Maine-based company said it initially intended to raise $4 million, but found “substantial interest” and ended up netting extra funds. MedRhythms added that it has already closed $5 million from the round.

FUNDING SERIES A
View Analyst & Ambassador Comments
Go to original news
Jul 03,2017

Theranica Raises $6M to Combat Migraine

Theranica Bio-Electronics, a bio-medical technology company developing advanced electroceuticals for migraine and other prevalent diseases, announced the closing of its round A of financing, led by Lightspeed Venture Partners. Other investors participating in the round are LionBird venture capital firm and Corundum Open Innovation. The funds, totaling about $6M will be used mainly to complete the regulatory process of the company's first product, for acute treatment of migraine, and to bring the product to mass production.

FUNDING SERIES A
View Analyst & Ambassador Comments
Go to original news
Feb 03,2016

Pear Therapeutics raises $20M for digital combination interventions, starting with substance use disorders

Pear Therapeutics, which is developing interventions that combine digital tools and medications, has raised $20 million in a round led by 5AM Ventures, Arboretum Ventures, and Jazz Venture Partners, with participation from Bridge Builders Collaborative. The company raised its last round, which was undisclosed, in March 2015. Pear Therapeutics’s product, called eFormulations, combines medication for a specific condition with a digital therapy program. he eFormulations product will be prescribed by physicians to their patients. Depending on the patient's condition, the software component of the offering could include games, tracking tools, and other engagement features. Pear Therapeutics will use the funds to launch its first eFormulations, called reSET and reSET-O, which are designed to treat substance use disorder (SUD).

FUNDING SERIES A
View Analyst & Ambassador Comments
Go to original news
Feb 17,2016

MindMaze, The World’s First Multisensory Computing Platform, Raises Commitments Of $100 Million In New Funding Round

MindMaze, the world’s first end-to-end multisensory computing platform, today announced it has raised commitments of $100 million in a new round led by the Hinduja Group, the 102-year-old global conglomerate that has invested since the company’s early stages, with participation from family offices. Also announcing its recent pre-money valuation of more than $1 billion, MindMaze will build further on its track record for launching top-end medical-grade neural virtual reality platforms.

FUNDING SERIES A
View Analyst & Ambassador Comments
Go to original news
Jan 19,2022

NuvoAir Series A Funding Reaches $25M to Expand Patient-Centric Care and Clinical Trials Platform

NuvoAir, a leading digital healthcare company working in chronic disease management, raised $11M in a latest round of financing. The investment was led by Hikma Pharmaceuticals’ venture capital arm, Hikma Ventures, and is an extension of the Series A round, previously announced in June 2021. Additional participation from a new strategic investor and existing investors brings the total Series A round to $25 million.

FUNDING SERIES A
View Analyst & Ambassador Comments
Go to original news
Subscribe to SERIES A